School of Medicine
Showing 12,101-12,200 of 13,086 Results
-
Sui Wang, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.
1. Investigating retinal development:
We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.
2. Understanding diabetes-induced cell-type-specific responses in the retina:
Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.
3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo. -
Taia T. Wang, MD, PhD, MSCI
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsLaboratory of Mechanisms in Human Immunity and Disease Pathogenesis
-
Tao Wang (王韬)
Director of Precision Diabetes Care, Genetics
Current Role at StanfordPrincipal Investigator, AI for Precision Diabetes Management
Project Manager & Scientific Co-lead, PsychENCODE Project
Project Initiator & Clinical Co-lead, Long COVID Clinical RCT with TCM
Project Initiator & Manager, AI & Wearables Toolkit for Biomedical Sciences
ENCODE and PsychENCODE Project Data Manager
Research Scientist, US Veteran Affairs Hospital
SCGPM HPC System Administrator -
Tong Wang
Instructor, Pathology
BioTong Wang, MD, PhD, is a physician-scientist in clinical pathology with interests in nucleic acid chemical biology, epigenetics, deep learning, and clinically useful tests.
-
Tony Wang
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioTony Wang is a Clinical Assistant Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. He is a board-certified anesthesiologist and intensivist with clinical expertise in critical care medicine and liver transplant anesthesiology.
Dr. Wang completed his medical school training, anesthesiology residency, and critical care fellowship at the Johns Hopkins School of Medicine. Dr. Wang is deeply committed to medical education and academic innovation. He serves as the Associate Program Director for the Liver Transplant Anesthesiology Fellowship and is the founding director of Stanford's Anesthesiology Critical Care Education for Leaders (ACCEL) program. He is also Director of Residency Engagement for WikiAnesthesia, a comprehensive digital platform designed to serve as an open-access repository of anesthesia knowledge for trainees and practitioners.
Prior to medicine, Dr. Wang worked as a software engineer at Epic Systems, where he developed an appreciation for the intersection of technology and healthcare delivery.
His clinical interests include the perioperative management of complex patients, liver transplant anesthesiology, critical care medicine, and the integration of technology into anesthesiology education. -
Wenjun Wang
Postdoctoral Scholar, Stem Cell Transplantation
Current Research and Scholarly InterestsMy postdoctoral research focuses on investigating novel therapy for childhood leukemias.
-
Wenmin Wang
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsI am particularly interested in identifying therapeutic strategies for various eye disorders and investigating the mechanisms by which defects in inositol phosphatases lead to the disruption of primary cilia function and eye diseases by using Omics.
-
Xinnan Wang
Professor of Neurosurgery
Current Research and Scholarly InterestsMechanisms underlying mitochondrial dynamics and function, and their implications in neurological disorders.
-
Tauska Lan
Affiliate, Genetics - BASE
BioI'm an ML engineer specializing in LLM post-training and agentic systems—with a particular focus on domains where rigor matters: health, biology, and scientific discovery.
Long-horizon agents — Designed and shipped multi-step orchestration systems (Pantheon-CLI, OmicVerse Agent) that outperform general SWE-agent baselines on biomedical tasks. Built cross-provider query routing and sandboxed execution to keep complex workflows robust over extended interactions. My agents don't just respond—they plan, recover from failure, and complete real research pipelines end-to-end.
Agentic science — Created infrastructure where AI doesn't assist research—it conducts it. Vectorized 30 years of NHANES data; parallelized Bayesian kernel machine regression on Kubernetes; built TCGA/GEO pipelines that bridge wet-lab and dry-lab workflows. Co-developed OmicVerse, an open-source platform powering reproducible multi-omics and single-cell analyses across hundreds of studies.
Experience engineering — Scaled rubric-based reward datasets to 1M+ pairs; trained summary and chain-of-thought reward models via RLAIF/RLHF; delivered measurable benchmark lifts in health AI. I care about the full loop: data curation → reward shaping → careful ablation → verifiable outcome—no cherry-picked demos—just metrics that survive scrutiny.
Currently pursuing advanced agentic studies at Karolinska Institutet and Stanford!
Open-source: OmicVerse · Pantheon-CLI · RAG Web UI · AstrBot
If you're working on post-training at scale, scientific agents, or high-integrity data pipelines—I'm always interested in systems that move from promising results to verifiable outcomes. Let's talk. -
Xunda Wang
Basic Life Res Scientist, Neurosurgery
Current Role at StanfordResearch Scientist
-
Yidan Wang
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioI joined Dr. John Benjamin’s lab to study the heterogeneity of neutrophils across developmental stages and during bronchopulmonary dysplasia (BPD). My research focuses on characterizing neutrophil subsets and investigating the contributions of distinct neutrophil subsets to the development of BPD.
My predoctoral training was completed at Northwestern University under the co-mentorship of Dr. Harris Perlman and Dr. Deborah Winter. I studied the heterogeneity and functions of monocyte-lineage cells and macrophages in mouse synovial tissue under both steady-state and inflammatory arthritis conditions. -
Yiyu Wang
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Yiyu Wang is a T32 postdoctoral researcher at the Department of Anesthesiology, Stanford School of Medicine. Her research combines computational models and neuroimaging techniques to characterize the neural architecture underlying complex human experiences in emotion and pain. Her current work focuses on leveraging deep learning, foundation models, and explainable AI to improve neuroimaging-based markers as well as multi-modal markers of chronic pain.
-
Dr. Zhiyong Wang
Visiting Scholar, Genetics
BioDr. Wang is the acting director of the Department of Plant Biology, Carnegie Institution for Science, and a professor by courtesy of the Department of Biology, Stanford University. He is currently an associate editor of Molecular Cellular Proteomics, and editorial board member of Molecular Plant. He is a Fellow of the American Association for the Advancement of Science (AAAS) and recipient of the Humboldt Research Prize.
Dr. Wang obtained his Ph.D. in 1998 from UCLA, where he cloned the plant circadian clock gene CCA1. He did his postdoctoral research at the Salk Institute, where he studied the brassinosteroid signaling mechanism mediated by the BRI1 receptor kinase. Since joining Carnegie in 2001, his research has illustrated the receptor kinase signaling pathway that links the BRI1 receptor kinase to the BZR1 transcription factor and brassinosteroid-responsive genes in the Arabidopsis genome. He further demonstrated how the steroid signaling pathway integrates at the molecular level with other hormonal pathways, light signaling pathways, nutrient-sensing pathways, immunity pathways, and the circadian clock, to coordinately regulate plant growth and development. His lab uses combinations of genomic and proteomic approaches to understand how cellular signals are transduced and integrated through posttranslational modifications (e.g. phosphorylation and O-Glycosylation) and protein-protein interactions. His studies are elucidating the molecular mechanisms that control plant growth and mediate responses to environmental changes. -
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
-
Zoey Wang
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsSleep disruptions in neurodegenerative disorders
-
Irene Wapnir, MD
Professor of Surgery (General Surgery)
Current Research and Scholarly InterestsClinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.
-
(Alex) Alexandra Ward
Clinical Research Coordinator Associate, Pediatrics - Endocrinology
Bio(Alex) Alexandra Ward is currently a Clinical Research Coordinator at Stanford School of Medicine in the Department of Pediatric Endocrinology. She holds a Bachelor's degree in Sociology from UC Berkeley and has a strong interest in the intersection of medicine and social science. Alexandra is particularly passionate about advancing health equity and studying the social determinants of health. Her experience spans clinical work, academic research, and community engagement.
-
Katherine T. Ward, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Ward is the Chief of the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine, and a Clinical Professor of Medicine. In this leadership role, she supervises program leaders across outpatient, inpatient, and skilled nursing facility settings, bringing them together to provide longitudinal, coordinated care to older adults across the healthcare continuum.
Dr. Ward is a fellowship-trained geriatrician with Stanford in Palo Alto, California, and is board certified in geriatric medicine, hospice and palliative medicine, and internal medicine. Her clinical practice spans all care settings—outpatient clinics, hospitals, and skilled nursing facilities—with a focus on managing the critical transitions between them. She specializes in comprehensive care for older adults, including dementia care, palliative care, geriatric assessment, and best practices in nursing home care. Dr. Ward draws on her extensive experience to teach and implement evidence based models that support care for older adults. Dr. Ward's research interests include early detection of dementia in vulnerable populations, dementia care support programs, and geriatric assessment in diverse populations.
She has published her research in peer-reviewed journals including the Journal of the American Geriatrics Society; The American Journal of Geriatric Pharmacotherapy; The Journal of Nutrition, Health & Aging; and the Journal of Palliative Medicine. She has served as an ad hoc reviewer for several journals, including Geriatrics, and has presented posters at annual meetings of the American Geriatrics Society and the Society of General Internal Medicine.
Dr. Ward is a member of the American College of Physicians and the American Geriatrics Society. -
Victoria Ward
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, digital health, preterm birth, human trafficking
-
Chisondi S. Warioba, PhD
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioChisondi S. Warioba, PhD, is a Postdoctoral Scholar in the Division of Pain Medicine at the Stanford University School of Medicine, working in the Department of Anesthesiology, Perioperative and Pain Medicine with Dr. Sean Mackey and Dr. Kenneth Weber. His research develops machine learning and deep learning approaches for high-dimensional medical data, with an emphasis on cross-species translational neuroscience, resting-state fMRI, and multimodal MRI analysis (NODDI, DKI, and advanced diffusion techniques) to identify brain biomarkers of chronic pain.
He earned his PhD in Medical Physics from the University of Chicago, where his dissertation focused on cross-species mapping of functional connectivity alterations and therapeutic responses in hyperacute ischemic stroke. He completed a triple-major bachelor's degree in Chemistry, Physics, and Biology at Westmont College.
Dr. Warioba is a National Science Foundation Graduate Research Fellow and was awarded an Academic Visitor position at the University of Oxford's Department of Clinical Neurosciences. He received the Carl B. Allendoerfer Award from the Mathematical Association of America for expository excellence. He is committed to mentorship and community engagement, including STEM outreach for underrepresented students and neuroscience public education. -
Roger Warnke
Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
Current Research and Scholarly InterestsAs an Emeritus Professor, I no longer have a research laboratory and am now fully retired.
-
Jenli Dawn Waters, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Waters is a board-certified, fellowship-trained neurosurgeon with the Neurosurgery Program at Stanford Health Care. She is also a clinical assistant professor of neurosurgery in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Waters specializes in treating a wide range of spinal conditions. These treatments include surgery to relieve numbness or pain related to pressure on the spinal cord and procedures to repair or stabilize the spinal column (spine fusion). Her areas of expertise also include diagnosis and treatment of traumatic brain injury and brain and spinal cancers.
Dr. Waters’ research experience includes helping to develop effective strategies for diagnosing
and treating patients with different neurological cancers, including glioblastomas. As a subspecialty medical expert for spine and neurosurgery, she successfully advocated for insurance coverage of state-of-the-art, minimally invasive approaches to treating epilepsy and brain tumors.
Dr. Waters has published her work in peer-reviewed journals, including the Journal of Neurosurgery and the Journal of Neuro-Oncology. She has also authored and co-authored chapters in numerous books describing neurosurgical techniques and the diagnosis and treatment of various neurological conditions, including brain and spinal cord tumors.
Dr. Waters is a member of the Congress of Neurological Surgeons. -
Ronald D. Watkins
Senior Research Engineer, Rad/Radiological Sciences Laboratory
Current Role at StanfordMy current position is Senior Research Associate in the Radiological Sciences Laboratory and the Molecular Imaging Laboratory in the Department of Radiology at Stanford School of Medicine. I provide hardware, systems, and general technical support for a large group of Faculty members and many students and post docs in the development of advanced medical imaging, metabolic imaging and image-guided interventions. My training background is primarily in RF and electrical engineering. I have spent more than 25 years in the commercial diagnostic imaging industry. Most of the projects I am currently working on involve instrumentation for metabolic imaging using magnetic deuterium imaging. I am also involved in the development of Hybrid systems that combine Positron Emission Tomography and Magnetic Resonance imaging. Other projects I am involved in use focused ultrasound for neuro-stimulation or drug delivery via blood brain barrier. I also provide RF coil design and support for small animal imaging and various research studies. I have ongoing collaborations with many other medical research institutes and Universities around the world. I currently have 45 issued US patents, and 100 pear reviewed publications.
-
Erin Watson, PsyD, ABPP
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Erin Watson is a board-certified clinical health psychologist and Clinical Associate Professor in the Division of Gastroenterology & Hepatology at Stanford University School of Medicine. She is a member of Stanford Health Care’s GI Behavioral Medicine program, where she specializes in the intersection of psychological health, behavioral science, and gastrointestinal and liver disease.
Dr. Watson’s clinical work focuses on helping patients navigate the emotional, behavioral, and lifestyle factors that influence medical illness. Her areas of expertise include health anxiety, stress and symptom management, health-behavior change, adjustment to chronic conditions, and the emerging specialty of psycho-hepatology. She uses practical, evidence-based approaches—including cognitive behavioral therapy, acceptance and commitment therapy, mindfulness-based interventions, and motivational interviewing—with lifestyle-medicine strategies to support long-term health and resilience. Her goal is to help patients feel more informed, supported, and empowered throughout their care.
In addition to her clinical work, Dr. Watson is engaged in research to advance behavioral treatments for chronic pain and develop new psychological interventions for individuals living with chronic liver disease. She is a co-investigator on a National Institutes of Health–funded study examining effective treatment options for veterans with chronic pain and addiction. Her scholarly work has been published in peer-reviewed journals and presented at regional and national conferences, including annual meetings of the American Psychological Association.
Dr. Watson is a Fellow of the American Academy of Clinical Health Psychology and a member of the American Psychological Association, the Society for Health Psychology (Division 38), the Society of Behavioral Medicine, the American Association for the Study of Liver Diseases, and the Rome Foundation. -
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Annika M. Weber
Postdoctoral Scholar, Gastroenterology
BioAnnika is a postdoctoral scholar in the Spencer Lab studying how gut microbes metabolize prebiotic fibers to produce bioactive metabolites linked to lowering disease risk. She holds an MS in Human Nutrition from the University of Sheffield and a PhD in Food Science and Human Nutrition from Colorado State University. Her work integrates multi-omic approaches to map diet-microbe-metabolite relationships. Annika aims to translate these mechanistic insights into microbiome-informed dietary strategies for reducing chronic diseases.
-
Kenneth Weber, DC, PhD
Assistant Professor (Research) of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Neurosurgery (Adult Neurosurgery) and of Radiology (Neuroimaging and Neurointervention)
BioDr. Weber directs the Neuromuscular Insight Lab. Dr. Weber's research seeks to develop quantitative markers of sensory and motor function, including pain, using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of neurological and musculoskeletal conditions and discover more effective treatments and preventative strategies.
-
Mike Tzuhen Wei
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Wei was born and raised in Taipei, Taiwan. He went to Stanford for his undergraduate studies in Biology and earned his medical degree at Weill Cornell Medical College. Unable to stay far from the Bay Area, he returned to Stanford where he completed his residency in internal medicine and subsequently his fellowship in gastroenterology. Dr. Wei has specific interests in colorectal cancer and Barrett’s esophagus surveillance as well as reflux diagnosis and management. He has an interest in endoscopic resection of large polyps and had received training under Dr. Shai Friedland, a world expert in this field. Dr. Wei work focuses on evaluating new tools, technologies and techniques in gastrointestinal cancer surveillance and management. He has been involved in running several trials in endoscopic management of polyps and evaluating artificial intelligence applications in gastroenterology. His work has been published in American Journal of Gastroenterology, Gastrointestinal Endoscopy, Clinical Endoscopy, VideoGIE, and Digestive Diseases and Sciences. He was formerly an Associate Editor for the ACG Case Report Journal (2020-2022) and was on the Board of the Northern California Society of Clinical Gastroenterology. When not in clinic or in endoscopy, Dr. Wei enjoys spending time with his family. He and his family enjoy traveling and exploring new restaurants.
-
Ruolun Wei
Postdoctoral Scholar, Neurosurgery
BioRuolun Wei, MD, PhD, is a postdoctoral scholar in the Department of Neurosurgery at Stanford University. Dr. Wei’s work centers on neuro-oncology, with particular emphasis on brain tumor recurrence, treatment resistance, and tumor metabolism. He is also a board-certified neurosurgeon, currently focusing on full-time research. His research aims to bridge the gap between clinical practice and laboratory investigation, conducting translational research that moves from bedside to bench and back to bedside to improve therapeutic outcomes for patients with malignant brain tumors.
-
Tan Wei Ting
Affiliate, Neurosurgery
BioWei Ting graduated from University Malaya under the Department of Biomedical Engineering (Bachelor & Master's).Apart from multidisciplinary (tissue engineering, medical imaging, computational biology) research experience, she has worked in startups, industry, clinics, and medical centres with exposure to rehabilitation robotics, TCM in fertility, and clinical trials.
Her past undergraduate research experience includes
1. Dr Belinda Murphy’s Tissue Engineering Lab to assist in cell culturing and cytotoxicity testing
2. Asian Cardiac Laboratory under Dr Lim Einly for medical imaging-based investigation of flow energetics and vortex parameters in heart attack patients
For master's research, funded under Newton Advanced Fellowship in collaboration with Imperial College London’s Prof Xu group and UTM's Dr Mohd Jamil’s group.
1. Research focus: investigating the risk factor of distal stent induced new entry in aortic dissection patients using both simplified and patient-specific models.
2. Presented in local and international conference, published peer review studies and has reviewed paper relevant to the project.
With curiosity for knowledge, arts, philosophy, and the sciences, she often diving into new fields, moves across disciplines, and combines several areas of knowledge. She gained both lab-based and computational skills, for example: bioinformatics, pharmacokinetic modelling, cell staining, confocal microscopy, FRET cell transfection, live cell imaging, image processing, high-performance computing, quantum algorithms, etc.
At MSU, she is part of the Tau Beta Pi National Honor Society and Cloud Computing Foundations (CCF) Program. For the cloud program, her interest is in applying a hybrid quantum-classical computational framework to small-molecule drug development. She is currently a PhD student in Biomedical Engineering from Michigan State University, performing computational analysis and exploring quantum algorithms for biomedical applications in cell and gene regulatory networks.
Wei Ting has been active in learning more about different facets of medicine and often engages with researchers and physicians. She has gained familiarity with neurological disease (e.g. autism, Parkinson's, and Alzheimer's) from different perspectives (e.g., rehabilitation robotics, brain simulation, and psychiatry). She is invited to join the Neurobehavior and Neuroscience Methods Workshop (SPrINT/Stanford) in 2026.
